SCHEMBL7940253

SCHEMBL7940253

COc1ccc2c(Oc3ccc([N+](=O)[O-])cc3)c(-c3ccc(OC)c(Cl)c3)ccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR9 Q9NR96 1/20 0.44
PDE7A Q13946 1/20 0.41
MAPT P10636 6/20 0.41
HPGD P15428 3/20 0.41
HNF4A P41235 1/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
LMNA P02545 2/20 0.39
GAA P10253 1/20 0.39
PKM P14618 1/20 0.39
APP P05067 1/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7940260 0.93 TLR9 (0.42) TLR9PDE7AMAPTHPGDHNF4A
SCHEMBL7937733 0.90 MAPT (0.43) PDE7AMAPTHPGDMEN1KMT2A
SCHEMBL7940195 0.88 HSPB1 (0.46) TLR9MAPTHNF4AMEN1KMT2A
SCHEMBL7937836 0.87 APP (0.48) TLR9MAPTHPGDHNF4AMEN1
SCHEMBL7935034 0.84 PLAU (0.40) TLR9MAPTHPGDHNF4AKMT2A
SCHEMBL7928854 0.84 MAOB (0.47) TLR9HNF4AMEN1KMT2ASMN1; SMN2
SCHEMBL7937985 0.84 DHFR (0.41) SMN1; SMN2APPCYP1A2CYP3A4CYP2D6
SCHEMBL7190071 0.83 GSTP1 (0.39) MAPTHPGDNPC1CYP1A2RAB9A
SCHEMBL3121428 0.81 PTGS2 (0.53) HNF4AAPPPTGS2
SCHEMBL3111379 0.81 PIK3CA (0.42) TLR9MAPTHNF4AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0835868-B1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods LILLY CO ELI (US) 2001-08-29 EP disclosed
US-5929090-A NOVEL COMPOUNDS FOR TREATING ESTROGEN DEPRIVATION CAUSED BY MENOPAUSE OR OVARIECTOMY; TREATING OSTEOPOROSIS, CARDIOVASCULAR DISEASES, AND ENDOMETRIOSIS ELI LILLY AND COMPANY (US) 1999-07-27 US disclosed
EP-0835868-A1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods ELI LILLY AND COMPANY (US) 1998-04-15 EP disclosed